<DOC>
	<DOCNO>NCT00132600</DOCNO>
	<brief_summary>The purpose study establish concentration bacitracin-patch diagnose allergic contact dermatitis .</brief_summary>
	<brief_title>Clinical Evaluation Bacitracin</brief_title>
	<detailed_description>Thin-layer Rapid Use Epicutaneous Test ( T.R.U.E . TestÂ® ) ready-to-use patch test method design diagnosis allergic contact dermatitis . The standard panel consist two tape strip , panel 1 , 11 allergen patch negative control panel 2 , 12 allergen patch . T.R.U.E . TestTM panel 1 2 contain 23 frequent contact allergen . With 23 allergen test currently consist , possible detect 60-70 % contact allergic reaction . Thus , need expand number allergen include T.R.U.E.Test order detect contact allergic reaction . Bacitracin one allergens , purpose study determine concentration patch use bacitracin dilution series .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Contact</mesh_term>
	<mesh_term>Dermatitis , Allergic Contact</mesh_term>
	<mesh_term>Bacitracin</mesh_term>
	<criteria>Positive bacitracin patch test within late 5 year . Age great equal 18 year . Signed informed consent . Topical treatment corticosteroid immunosuppressives late 7 day test area near test area . Systemic treatment corticosteroid immunosuppressives late 7 day . Treatment ultraviolet ( UV ) light late 3 week . Widespread active dermatitis dermatitis test area . Breastfeeding pregnancy . Females childbearing potential must demonstrate negative pregnancy test inclusion study . Subjects able cooperate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>Allergic contact dermatitis</keyword>
	<keyword>Patch test</keyword>
	<keyword>bacitracin</keyword>
</DOC>